Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy OKYO Pharma Ltd ADR stock

Learn how to buy OKYO Pharma Ltd ADR stock in 5 easy steps.

OKYO Pharma Ltd ADR is a biotechnology business based in the US. OKYO Pharma Ltd ADR shares (OKYO) are listed on the NASDAQ and all prices are listed in US Dollars. OKYO Pharma Ltd ADR employs 7 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy OKYO Pharma Ltd ADR stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – OKYO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

OKYO Pharma Ltd ADR stock price (NASDAQ: OKYO)

Use our graph to track the performance of OKYO stocks over time.

OKYO Pharma Ltd ADR shares at a glance

Information last updated 2022-12-07.
Latest market close$1.68
52-week range$1.81 - $6.11
50-day moving average $2.29
200-day moving average $2.32
Wall St. target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.01

Buy OKYO Pharma Ltd ADR stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy OKYO Pharma Ltd ADR stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OKYO Pharma Ltd ADR price performance over time

Historical closes compared with the close of $1.68 from 2023-03-31

1 week (2023-03-22) 12.75%
1 month (2023-03-01) -24.66%
3 months (2022-12-30) -12.04%
6 months (2022-09-30) -36.12%
1 year (2022-03-28) N/A
2 years (2021-03-28) N/A
3 years (2020-03-28) N/A
5 years (2018-03-28) N/A

OKYO Pharma Ltd ADR financials

Gross profit TTM $-3,599,629
Return on assets TTM -67.65%
Return on equity TTM -130.43%
Profit margin 0%
Book value $0.13
Market capitalisation $46.5 million

TTM: trailing 12 months

OKYO Pharma Ltd ADR share dividends

We're not expecting OKYO Pharma Ltd ADR to pay a dividend over the next 12 months.

OKYO Pharma Ltd ADR share price volatility

Over the last 12 months, OKYO Pharma Ltd ADR's shares have ranged in value from as little as $1.81 up to $6.11. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OKYO Pharma Ltd ADR's is -0.1069. This would suggest that OKYO Pharma Ltd ADR's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OKYO Pharma Ltd ADR has bucked the trend.

OKYO Pharma Ltd ADR overview

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom. .

Frequently asked questions

What percentage of OKYO Pharma Ltd ADR is owned by insiders or institutions?
Currently 0.057% of OKYO Pharma Ltd ADR shares are held by insiders and 0.005% by institutions.
How many people work for OKYO Pharma Ltd ADR?
Latest data suggests 7 work at OKYO Pharma Ltd ADR.
When does the fiscal year end for OKYO Pharma Ltd ADR?
OKYO Pharma Ltd ADR's fiscal year ends in March.
Where is OKYO Pharma Ltd ADR based?
OKYO Pharma Ltd ADR's address is: 55 Park Lane, London, United Kingdom, W1K 1NA
What is OKYO Pharma Ltd ADR's ISIN number?
OKYO Pharma Ltd ADR's international securities identification number is: US6793451088

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site